Whom and where are we not vaccinating? coverage after the introduction of a new conjugate vaccine against group a meningococcus in Niger in 2010

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Kim, Sung Hye ^a,d   Pezzoli, Lorenzo ^b   Yacouba, Harouna ^c   Coulibaly, Tiekoura ^d   Djingarey, Mamoudou H ^d   Perea, William A ^d   Wierzba, Thomas F ^a  

^a International Vaccine Institute   (South Korea)

^b Consultant for the Meningitis Vaccine Project ^*  (United Kingdom)

^c Ministry of Public Health   (Niger)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE; VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ARTICLE; BACTERIAL MENINGITIS; CHILD; FEMALE; HEALTH CARE DISTRIBUTION; HEALTH CARE SURVEY; HEALTH PROGRAM; HUMAN; LOT QUALITY ASSURANCE SAMPLING; MALE; NIGER; SCHOOL CHILD; ADULT; IMMUNOLOGY; INFANT; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; STATISTICS; VACCINATION;

NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS SEROGROUP A;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEISSERIA MENINGITIDIS, SEROGROUP A; NIGER; VACCINATION; VACCINES, CONJUGATE; YOUNG ADULT;

EID: 84856108823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029116     Document Type: Article

References (26)

1. Greenwood B, (1999) Manson Lecture. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93: 341-353.
2. World Health Organization (WHO) (2010) Meningitis in Chad, Niger and Nigeria: 2009 epidemic season. Wkly Epidemiol Rec 85: 47-63.
3. WHO (1997) Response to epidemic meningitis in Africa, 1997. Wkly Epidemiol Rec 72: 313-318.
4. LaForce FM, Konde K, Viviani S, Preziosi MP, (2007) The Meningitis Vaccine Project. Vaccine 25 (Suppl 1): A97-100 S0264-410X(07)00474-4 [pii];10.1016/j.vaccine.2007.04.049 [doi].
5. Thompson F, (2011) End of a century-long scourge? Bull World Health Organ 89: 550-551 10.2471/BLT.11.020811 [doi];BLT.11.020811 [pii].
6. LaForce FM, Okwo-Bele JM, (2011) Eliminating epidemic group a meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood) 30: 1049-1057 30/6/1049 [pii];10.1377/hlthaff.2011.0328 [doi].
7. WHO (2010) Global Advisory Committee on Vaccine Safety, report of meeting held 16-17 June 2010. Wkly Epidemiol Rec 84: 325-332.
8. World Health Organization (2005) Immunization coverage cluster survey- reference manual Geneva World Health Organization.
9. Hoshaw-Woodard S, (2001) Description and comparison of the methods of cluster sampling and lot quality assurance sampling to assess immunization coverage.
10. World Health Organization (1996) Monitoring immunization services using the Lot Quality Technique Geneva World Health Organization.
11. WHO (2005) Immunization coverage cluster survey- reference manual Geneva World Health Organization.
12. Myatt M, (2001) SampleLQ: a sample size calculator for community-based triage survey using lot quality assurance sampling. Brixton Health ICEH.
13. Lanata CF, Stroh G Jr, Black RE, Gonzales H, (1990) An evaluation of lot quality assurance sampling to monitor and improve immunization coverage. Int J Epidemiol 19: 1086-1090.
14. Pezzoli L, Andrews N, Ronveaux O, (2010) Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precision. Trop Med Int Health 15: 540-546 TMI2482 [pii];10.1111/j.1365-3156.2010.02482.x [doi].
15. Pezzoli L, Pineda S, Halkyer P, Crespo G, Andrews N, et al. (2009) Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007. Trop Med Int Health 14: 355-361 TMI2231 [pii];10.1111/j.1365-3156.2009.02231.x [doi].
16. Trotter CL, Gay NJ, Edmunds WJ, (2005) Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 162: 89-100 162/1/89 [pii];10.1093/aje/kwi160 [doi].
17. Stephens DS, (2004) Herd Immunity from Meningococcal Serogroup C Conjugate Vaccination. Curr Infect Dis Rep 6: 351-352.
18. Stephens DS, (2008) Vaccines for the unvaccinated: protecting the herd. J Infect Dis 197: 643-645 10.1086/527402 [doi].
19. Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, et al. (2011) Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med 364: 2293-2304 10.1056/NEJMoa1003812 [doi].
20. Haddad S, Bicaba A, Feletto M, Fournier P, Zunzunegui MV, (2010) Heterogeneity in the validity of administrative-based estimates of immunization coverage across health districts in Burkina Faso: implications for measurement, monitoring and planning. Health Policy Plan 25: 393-405 czq007 [pii];10.1093/heapol/czq007 [doi].
21. Borgdorff MW, Walker GJ, (1988) Estimating vaccination coverage: routine information or sample survey? J Trop Med Hyg 91: 35-42.
22. Zuber PL, Yameogo KR, Yameogo A, Otten MW Jr, (2003) Use of administrative data to estimate mass vaccination campaign coverage, Burkina Faso, 1999. J Infect Dis 187 (Suppl 1): S86-S90 JID020659 [pii];10.1086/368052 [doi].
23. Singh J, Jain DC, Sharma RS, Verghese T, (1996) Evaluation of immunization coverage by lot quality assurance sampling compared with 30-cluster sampling in a primary health centre in India. Bull World Health Organ 74: 269-274.
24. Deitchler M, Valadez JJ, Egge K, Fernandez S, Hennigan M, (2007) A field test of three LQAS designs to assess the prevalence of acute malnutrition. Int J Epidemiol 36: 858-864.
25. Greenland K, Rondy M, Chevez A, Sadozai N, Gasasira A, et al. (2011) Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage. Trop Med Int Health 10.1111/j.1365-3156.2011.02770.x [doi].
26. Pezzoli L, Tchio R, Dzossa AD, Ndjomo S, Takeu A, et al. (2011) Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009. Epidemiol Infect pp. 1-13 S0950268811000331 [pii];10.1017/S0950268811000331 [doi].